MENLO PARK, CA
Allocation by class
Portfolio Concentration
Top 3 weight
85.8%
Top 10 weight
98.2%
Voting Authority Distribution
Total shares with voting rights: 54.50M
Full voting authority
54.50M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $431.23M 65.21% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $111.34M 16.84% | 25.95M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 2.72M | SH | $24.52M 3.71% | 2.72M | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $15.16M 2.29% | 4.04M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $14.77M 2.23% | 3.92M | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 692.05K | SH | $13.88M 2.10% | 692.05K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 325.06K | SH | $10.41M 1.57% | 325.06K | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 477.82K | SH | $10.32M 1.56% | 477.82K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 93.50K | SH | $9.09M 1.37% | 93.50K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $8.89M 1.34% | 4.45M | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 3.80M | SH | $6.23M 0.94% | 3.80M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 1.32M | SH | $3.10M 0.47% | 1.32M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 7.30K | SH | $1.89M 0.29% | 7.30K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $477.1K 0.07% | 326.81K | 0.00 | 0.00 |